Author
Listed:
- Benjamin J. Burwitz
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Jochen M. Wettengel
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich)
- Martin A. Mück-Häusl
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich)
- Marc Ringelhan
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich
Klinikum rechts der Isar Technical University of Munich)
- Chunkyu Ko
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich)
- Marvin M. Festag
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich)
- Katherine B. Hammond
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Mina Northrup
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Benjamin N. Bimber
(Oregon National Primate Research Center, Oregon Health and Science University)
- Thomas Jacob
(Oregon Health and Science University)
- Jason S. Reed
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Reed Norris
(Oregon National Primate Research Center, Oregon Health and Science University)
- Byung Park
(Public Health and Preventative Medicine, Oregon Health and Science University)
- Sven Moller-Tank
(The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill)
- Knud Esser
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich)
- Justin M. Greene
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Helen L. Wu
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Shaheed Abdulhaqq
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- Gabriela Webb
(Vaccine and Gene Therapy Institute, Oregon Health and Science University)
- William F. Sutton
(Oregon National Primate Research Center, Oregon Health and Science University)
- Alex Klug
(Oregon National Primate Research Center, Oregon Health and Science University)
- Tonya Swanson
(Oregon National Primate Research Center, Oregon Health and Science University)
- Alfred W. Legasse
(Oregon National Primate Research Center, Oregon Health and Science University)
- Tania Q. Vu
(Oregon Health and Science University
Center for Spatial Systems Bioscience, Oregon Health and Science University)
- Aravind Asokan
(The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill)
- Nancy L. Haigwood
(Oregon National Primate Research Center, Oregon Health and Science University)
- Ulrike Protzer
(Institute of Virology, Technical University of Munich/Helmholtz Zentrum Munich
German Center for Infection Research, Munich partner site)
- Jonah B. Sacha
(Vaccine and Gene Therapy Institute, Oregon Health and Science University
Oregon National Primate Research Center, Oregon Health and Science University)
Abstract
Hepatitis B virus (HBV) is a major global health concern, and the development of curative therapeutics is urgently needed. Such efforts are impeded by the lack of a physiologically relevant, pre-clinical animal model of HBV infection. Here, we report that expression of the HBV entry receptor, human sodium-taurocholate cotransporting polypeptide (hNTCP), on macaque primary hepatocytes facilitates HBV infection in vitro, where all replicative intermediates including covalently closed circular DNA (cccDNA) are present. Furthermore, viral vector-mediated expression of hNTCP on hepatocytes in vivo renders rhesus macaques permissive to HBV infection. These in vivo macaque HBV infections are characterized by longitudinal HBV DNA in serum, and detection of HBV DNA, RNA, and HBV core antigen (HBcAg) in hepatocytes. Together, these results show that expressing hNTCP on macaque hepatocytes renders them susceptible to HBV infection, thereby establishing a physiologically relevant model of HBV infection to study immune clearance and test therapeutic and curative approaches.
Suggested Citation
Benjamin J. Burwitz & Jochen M. Wettengel & Martin A. Mück-Häusl & Marc Ringelhan & Chunkyu Ko & Marvin M. Festag & Katherine B. Hammond & Mina Northrup & Benjamin N. Bimber & Thomas Jacob & Jason S. , 2017.
"Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques,"
Nature Communications, Nature, vol. 8(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01953-y
DOI: 10.1038/s41467-017-01953-y
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Yongzhen Liu & Thomas R. Cafiero & Debby Park & Abhishek Biswas & Benjamin Y. Winer & Cheul H. Cho & Yaron Bram & Vasuretha Chandar & Aoife K. O’ Connell & Hans P. Gertje & Nicholas Crossland & Robert, 2023.
"Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Sreya Biswas & Lauren N. Rust & Jochen M. Wettengel & Sofiya Yusova & Miranda Fischer & Julien N. Carson & Josie Johnson & Lei Wei & Trason Thode & Mohan R. Kaadige & Sunil Sharma & Majd Agbaria & Ben, 2022.
"Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity,"
Nature Communications, Nature, vol. 13(1), pages 1-12, December.
- Kaho Shionoya & Jae-Hyun Park & Toru Ekimoto & Junko S. Takeuchi & Junki Mifune & Takeshi Morita & Naito Ishimoto & Haruka Umezawa & Kenichiro Yamamoto & Chisa Kobayashi & Atsuto Kusunoki & Norimichi , 2024.
"Structural basis for hepatitis B virus restriction by a viral receptor homologue,"
Nature Communications, Nature, vol. 15(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01953-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.